What are you searching for?

Sign in
Company News

Divine Skin Posts Record Quarterly Results

Q2 sales top $2.3 million

Author Image

By: TOM BRANNA

Editor

Divine Skin Inc. posted its highest quarterly revenue, $2.33 million, in the second quarter, 79% ahead of the same period in 2010.

“One of our challenges has been keeping up with demand,” said Divine Skin CEO Daniel Khesin. “We have invested significant resources into setting up a more robust operations platform. Now we have the right people in the right jobs managing the right plans for procurement, manufacturing, and accounting infrastructure. We will therefore continue to scale up to much more impressive numbers.”
The results come after a busy four months of announcements:
  • Naming of cosmetics veteran Robin Powell, respected for his success at Sebastian and TIGI, as president.
  • Explosive growth in salon distribution, including new channels totaling thousands of additional doors both domestically and abroad.
  • Plans for an oral analgesic to compete with Tylenol, Advil, and aspirin.
  • Expansion into advanced nutritional supplements with NutraOrigin.
  • Agreement for India’s largest pharmaceutical company to sell DS Laboratories treatments.
Divine Skin’s ongoing clinical studies for topical therapies have helped identify new molecules and many proprietary technologies in the treatment of common skin conditions such as alopecia. Recently the company launched of Nanoxidil, a new material to designed to surpass the efficacy of minoxidil.
“At the heart of this business is the relentless drive for innovation of personal care products,” commented Khesin. “Every day we are only getting better at what we do and creativity is reaching new horizons. Customers and shareholders should prepare for very exciting things to come,” he added.

Keep Up With Our Content. Subscribe To Happi Newsletters